1. Home
  2. CNXN vs NRIX Comparison

CNXN vs NRIX Comparison

Compare CNXN & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CNXN

PC Connection Inc.

HOLD

Current Price

$57.31

Market Cap

1.5B

ML Signal

HOLD

Logo Nurix Therapeutics Inc.

NRIX

Nurix Therapeutics Inc.

HOLD

Current Price

$14.70

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNXN
NRIX
Founded
1982
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
CNXN
NRIX
Price
$57.31
$14.70
Analyst Decision
Strong Buy
Analyst Count
0
12
Target Price
N/A
$30.58
AVG Volume (30 Days)
54.0K
933.5K
Earning Date
04-29-2026
04-10-2026
Dividend Yield
1.40%
N/A
EPS Growth
N/A
N/A
EPS
3.27
N/A
Revenue
N/A
$76,987,000.00
Revenue This Year
$6.24
N/A
Revenue Next Year
$4.39
$26.32
P/E Ratio
$17.48
N/A
Revenue Growth
N/A
99.31
52 Week Low
$54.97
$8.18
52 Week High
$71.17
$22.50

Technical Indicators

Market Signals
Indicator
CNXN
NRIX
Relative Strength Index (RSI) 39.62 42.06
Support Level $56.09 $11.34
Resistance Level $59.71 $16.47
Average True Range (ATR) 1.64 0.84
MACD -0.13 0.03
Stochastic Oscillator 25.55 31.51

Price Performance

Historical Comparison
CNXN
NRIX

About CNXN PC Connection Inc.

PC Connection Inc is a provider of information technology solutions. It provides products such as computer systems, software and peripheral equipment, networking communications, and other products and accessories that company purchase from manufacturers and distributors. The company also offers services involving design, configuration, and implementation of IT solutions. It conducts business operations through three business segments namely Connection Business Solutions, Connection Enterprise Solutions, and Connection Public Sector Solutions. The company generates maximum revenue Connection Enterprise Solutions segment.

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

Share on Social Networks: